- Clone
- A15027F (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Monocyte chemotactic protein 3 (MCP-3), Small inducible cytokine subfamily A. member
- Isotype
- Mouse IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
630552 | 100 µg | $415 |
CCL7, also known as MCP-3, was initially purified from cytokine-stimulated human osteosarcoma cell line (MG-63) conditioned medium. CCL7 has high similarity with CCL2/MCP-1 (71%), CCL8/MCP-2 (58%), and CCL13/MCP-4 (59%) at the amino acid level. Chemokines play a key role in inflammation and, in the initial phase, CXC chemokines chemoattract polymorphonuclear leukocytes (PMNs). The next step in the inflammatory processes is directed in part by CC chemokines, including the monocyte chemoattractant proteins (CCL2, CCL7, CCL8, and CCL13) that chemoattract additional leukocytes subsets. It has been reported that matrix metalloproteinases (MMPs) regulate chemokine bioactivity, increasing or decreasing their chemoattractant property. MMP-8 and MMP-9 modulate CXC chemokines, and MMP-2 truncates the N-terminal of CCL7, eliminating the first four amino acids producing CCL7 (5-76 residues), which leads to a loss of activity. The truncated CCL7 binds to its receptor, but it does not induce signaling transduction. Monocyte chemoattractant proteins (MCPs) are truncated by different MMPs to create potent antagonists and induce decreases in inflammation. For example, MMP-13 cleaves CCL2 and CCL7 and generates potent receptor antagonists. Also, CCL7 and CCL2 both play important roles in the pathogenesis of systemic sclerosis (SSc). It has been described that they are overexpressed in SSc and activate collagen production in dermal fibroblasts. In addition, CCL7 and CCL21 are highly expressed in gastric cancer and are associated with lymph node metastasis and poor prognosis.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Human Recombinant CCL7 (MCP3) Protein
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
Direct ELISA - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by Direct ELISA. The optimal concentration of this reagent for the specific application and the experiment design should be established by the end-user.
- Additional Product Notes
-
This product is intended for sandwich-based immunoassay development on various assay platforms requiring antibody pairs. This antibody (clone A15027F) could function as capture antibody when paired with biotin anti-human CCL7 (MCP-3) (Cat. No. 630653) (clone A15027A) as the detection antibody and using Recombinant Human CCL7 (MCP-3) (carrier-free) protein as the assay standard.
Antigen Details
- Structure
- Chemokine
- Distribution
-
Fibroblasts, mast cells, astrocytes, endothelial cells, monocytes, and macrophages
- Function
- CCL7 chemoattracts monocytes, T cells, NK cells, eosinophils, and basophils. CCL7 protein is secreted by mononuclear leukocytes after stimulation with IL1β, IFN-α, IFN-β, measles virus, poly I-C, or Con A. In fibroblasts, CCL7 mRNA and protein are synergistically induced after treatment with IL-1β and IFN-γ. CCL7 is stimulated in murine fibroblasts and astrocytes by TGF-β and TNF-α respectively. Anti-inflammatory cytokines (IL-4, IL-10, or IL-13) inhibit the expression of CCL7 in monocytes.
- Interaction
- Monocytes, T cells, NK cells, dendritic cells, mast cells, eosinophils, and basophils
- Ligand/Receptor
- CCR1 (CD191), CCR2 (CD192), CCR3 (CD193), and CCR5 (CD195).
- Cell Type
- Embryonic Stem Cells
- Biology Area
- Cancer Biomarkers, Neuroinflammation, Neuroscience, Stem Cells
- Antigen References
-
- Van Damme J, et al. 1992. J Exp Med. 176:59-65.
- Menten P, et al. 1999. Eur J Immunol. 29:678-85.
- McQuibban GA, et al. 2000. Science. 289:1202-6.
- Menten P, et al. 2001. Eur Cytokine Netw. 12:554-60.
- Dean RA, et al. 2008. Blood. 112:3455-64.
- Renner NA, et al. 2011. J Neurovirol. 17:146-52.
- Hwang TL, et al. 2012. World J Gastroenterol. 18:1249-56.
- Feuser K, et al. 2012. Cytokine. 58:178-85.
- Gene ID
- 6354 View all products for this Gene ID
- UniProt
- View information about CCL7 on UniProt.org
Related FAQs
Other Formats
View All CCL7 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-human CCL7 (MCP-3) | A15027F | Direct ELISA |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Purified anti-human CCL7 (MCP-3)
Direct ELISA showing purified anti-human CCL7 (MCP-3) (clone...
Follow Us